SB 450 (2022)
Revise laws for Prescription Drug Affordability Board
This bill became law.
Expands the ability of alternates to sit on the New Hampshire Prescription Drug Affordability Board, revises the board's conflict of interest requirements, and revises some fee assessments related to pharmacy benefits managers.
The Senate rewrote the bill. The rewritten bill still expands the ability of alternates to sit on the New Hampshire Prescription Drug Affordability Board. The bill also clarifies the definition of manufacturer and pricing unit for purposes of the Prescription Drug Affordability Board; clarifies the board's authority to assess fees; establishes a dedicated fund to support the board; and establishes a criminal penalty for violation of confidentiality requirements.
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills.
